Key facts
- Wisdom Tech’s last known valuation is $20.3M (Jan 2025).
- It has raised $2.8M; the latest was Later Stage VC ($1.4M) in Jan 2025.
- Notable investors include Hefei Industry Investment Group, Hefei Hi-Tech VC.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Wisdom Tech
- ·The full record, as it builds
Funding rounds
No funding rounds for Wisdom Tech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Wisdom Tech
Developer of radiation therapy planning and quality management solutions intended to enhance the precision and efficiency of radiotherapy treatments. The company offers a range of products, including DeepContour for automatic delineation of tumor targets and organs at risk, ArcherQA for radiation therapy verification, DeepPlan® for online adaptive radiotherapy planning, and ArcherFilm for film dose analysis, serving healthcare providers and radiotherapy centers to have advanced software and equipment for treatment.
- Sector
- Healthcare
- HQ
- Hefei, China
- Founded
- 2017
- Employees
- 15
- Website
- wisdom-tech.com.cn/
- Ownership
- Privately Held (backing)
Wisdom Tech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wisdom Tech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wisdom Tech in its N-PORT filings yet. We sweep new filings monthly.